Skip to main content
Charlotte Sumner, MD, Neurology, Baltimore, MD

Charlotte Jane Sumner MD

Neuromuscular Medicine


Associate Professor of Neurology, Johns Hopkins University School of Medicine

Join to View Full Profile
  • 601 North Caroline StreetBaltimore, MD 21287

  • Phone+1 410-955-9441

  • Fax+1 410-955-6402

Dr. Sumner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a board certified neurologist who specializes in neuromuscular disorders. Areas of particular expertise include inherited peripheral nerve, motor neuron, and muscle diseases such as Charcot Marie Tooth disease, spinal muscular atrophy, and muscular dystrophy.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Neurology, 1997 - 2000
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - Present
  • MD State Medical License
    MD State Medical License 2007 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Press Mentions

  • 2022 Cure SMA Annual Research Meeting Summaries – Special and Clinical Research Session
    2022 Cure SMA Annual Research Meeting Summaries – Special and Clinical Research SessionAugust 15th, 2022
  • News from the AAN Annual Meeting: In Phase 3 Results, Infants on Nusinersen Survive Longer, Achieve Motor Milestones
    News from the AAN Annual Meeting: In Phase 3 Results, Infants on Nusinersen Survive Longer, Achieve Motor MilestonesMay 18th, 2017
  • SMA Infants Do Better with Nusinersen
    SMA Infants Do Better with NusinersenApril 25th, 2017
  • Join now to see all

Grant Support

  • Translating Pathomechanisms into Treatment for Spinal Muscular AtrophiesJOHNS HOPKINS UNIVERSITY2021–2029
  • Muscle And Neuromuscular Junctions In Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2009–2012
  • Regulation Of The Survival Motor Neuron GeneNational Institute Of Neurological Disorders And Stroke2006–2008

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: